The efficacy and safety of Yokukansan for BPSD in Alzheimer's disease. a randomized, double-blind, placebo-control trial.
Phase 2
- Conditions
- Alzheimer's disease
- Registration Number
- JPRN-UMIN000004325
- Lead Sponsor
- Institute of Development, Aging and Cancer Tohoku university, Department of Geriatrics and Gerontology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 140
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with non-Alzheimer's dementia 2)No lesion exists in brain MRI. 3)Presence of severe illness 4)Those who have used Yokukansan ever before 5)Those who have joined any clinical trial within 3 month 6)Those who are thought inadequate by their doctor.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method